Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection

AIDS

Volumn 28, Issue 3, 2014, Pages 297-309

  Palmer, Clovis S ^a   Ostrowski, Matias ^b   Gouillou, Maelenn ^a   Tsai, Louis ^c   Yu, Di ^c   Zhou, Jingling ^a   Henstridge, Darren C ^d   Maisa, Anna ^a   Hearps, Anna C ^a,c   Lewin, Sharon R ^a,c,e   Landay, Alan ^f   Jaworowski, Anthony ^a,c   McCune, Joseph M ^g   Crowe, Suzanne M ^a,c,e  

^a BURNET INSTITUTE   (Australia)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c MONASH UNIVERSITY   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e ALFRED HOSPITAL   (Australia)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD4+ cells; Combination antiretroviral therapy; Glucose; Glucose transporter 1; HIV; Immune activation; Inflammation; Lymphocytes; Metabolism

Indexed keywords

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; YOUNG ADULT;

EID: 84894058359     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000128     Document Type: Article

References (48)

1. Jacobs SR, Herman CE, MacIver NJ, Wofford JA, Wieman HL, Hammen JJ, et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 2008; 180:4476-4486.
2. Marko AJ, Miller RA, Kelman A, Frauwirth KA. Induction of glucose metabolism in stimulated T lymphocytes is regulated by mitogen-activated protein kinase signaling. PLoS One 2010; 5:e15425.
3. Cham CM, Driessens G, O'Keefe JP, Gajewski TF. Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8R T cells. Eur J Immunol 2008; 38:2438-2450.
4. Gil L, Martinez G, Gonzalez I, Tarinas A, Alvarez A, Giuliani A, et al. Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res 2003; 47:217-224.
5. Kitchen CM, Yeghiazarian L, Hoh R, McCune JM, Sinclair E, Martin JN, et al. Immune activation, CD4R T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection. PLoS One 2011; 6:e21190.
6. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-155.
7. Hunt PW, Martin JN, Sinclair E, Epling L, Teague J, Jacobson MA, et al. Valganciclovir reduces T cell activation in HIVinfected individuals with incomplete CD4R T cell recovery on antiretroviral therapy. J Infect Dis 2011; 203:1474-1483.
8. Hunt PW, Landay AL, Sinclair E, Martinson JA, Hatano H, Emu B, et al. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One 2011; 6:e15924.
9. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009; 17:118-123.
10. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, et al. T cell activation is associated with lower CD4R T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187:1534-1543.
11. Hunt PW, Cao HL, Muzoora C, Ssewanyana I, Bennett J, Emenyonu N, et al. Impact of CD8R T-cell activation on CD4RT-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 2011; 25:2123-2131.
12. Fernandez S, Tanaskovic S, Helbig K, Rajasuriar R, Kramski M, Murray JM, et al. CD4R T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4R T cells. J Infect Dis 2011; 204:1927-1935.
13. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narvaez AB, et al. Immune activation set point during early HIV infection predicts subsequent CD4R T-cell changes independent of viral load. Blood 2004; 104:942-947.
14. Liu Z, Cumberland WG, Hultin LE, Kaplan AH, Detels R, Giorgi JV. CD8R T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:332-340.
15. Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4R T cell subsets. J Immunol 2011; 186:3299- 3303.
16. Finlay D, Cantrell DA. Metabolism, migration and memory in cytotoxic T cells. Nat Rev Immunol 2011; 11:109-117.
17. Fox CJ, Hammerman PS, Thompson CB. Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 2005; 5:844-852.
18. MacIver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 2008; 84:949-957.
19. Palmer CS, Crowe SM. The role of glucose and lipid metabolism in the pathogenesis of HIV-1 infection. Curr Trends Immunol 2012; 13:37-50.
20. Wieman HL, Wofford JA, Rathmell JC. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell 2007; 18:1437-1446.
21. Wofford JA, Wieman HL, Jacobs SR, Zhao Y, Rathmell JC. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5- mediated activation of Akt to support T-cell survival. Blood 2008; 111:2101-2111.
22. Sorbara LR, Maldarelli F, Chamoun G, Schilling B, Chokekijcahi S, Staudt L, et al. Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression. J Virol 1996; 70:7275-7279.
23. Hollenbaugh JA, Munger J, Kim B. Metabolite profiles of human immunodeficiency virus infected CD4R T cells and macrophages using LC-MS/MS analysis. Virology 2011; 415:153- 159.
24. Loisel-Meyer S, Swainson L, Craveiro M, Oburoglu L, Mongellaz C, Costa C, et al. Glut1-mediated glucose transport regulates HIV infection. Proc Natl Acad SciUS A 2012; 109:2549- 2554.
25. Michalek RD, Rathmell JC. The metabolic life and times of a T-cell. Immunol Rev 2010; 236:190-202.
26. Palmer C, Hampartzoumian T, Lloyd A, Zekry A. A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection. Hepatology 2008; 48:374-384.
27. Hearps AC, Maisa A, Cheng WJ, Angelovich TA, Lichtfuss GF, Palmer CS, et al. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS 2012; 26:843-853.
28. Jain P, Manuel SL, Khan ZK, Ahuja J, Quann K, Wigdahl B. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. J Virol 2009; 83:10908-10921.
29. Tanaka A, Jinno-Oue A, Shimizu N, Hoque A, Mori T, Islam S, et al. Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures. J Virol 2012; 86:2959-2969.
30. Chou JP, Ramirez CM, Wu JE, Effros RB. Accelerated aging in HIV/AIDS: novel biomarkers of senescent human CD8R T cells. PLoS One 2013; 8:e64702.
31. Ludlow LE, Zhou J, Tippett E, Cheng WJ, Hasang W, Rogerson SJ, et al. HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytes. PLoS One 2012; 7:e32102.
32. Kinet S, Swainson L, Lavanya M, Mongellaz C, Montel-Hagen A, Craveiro M, et al. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4R and CD8R T cells. Retrovirology 2007; 4:31.
33. Shin BC, McKnight RA, Devaskar SU. Glucose transporter GLUT8 translocation in neurons is not insulin responsive. J Neurosci Res 2004; 75:835-844.
34. Testi R, Phillips JH, Lanier LL. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [CaRR] and stimulation of protein kinase C. J Immunol 1989; 142:1854-1860.
35. Manel N, Kinet S, Battini J-L, Kim FJ, Taylor N, Sitbon M. The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood 2003; 101:1913-1918.
36. Maratou E, Dimitriadis G, Kollias A, Boutati E, Lambadiari V, Mitrou P, et al. Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur J Clin Invest 2007; 37:282-290.
37. Yu Y, Clippinger AJ, Alwine JC. Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol 2011; 19:360-367.
38. Takenouchi N, Jones KS, Lisinski I, Fugo K, Yao K, Cushman SW, et al. GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. J Virol 2007; 81:1506-1510.
39. Asano T, Katagiri H, Takata K, Lin JL, Ishihara H, Inukai K, et al. The role of N-glycosylation of GLUT1 for glucose transport activity. J Biol Chem 1991; 266:24632-24636.
40. Nakayama T, Kamiguchi H, Akagawa K. Syntaxin 1C, a soluble form of syntaxin, attenuates membrane recycling by destabilizing microtubules. J Cell Sci 2012; 125:817-830.
41. Chehtane M, Khaled AR. Interleukin-7 mediates glucose utilization in lymphocytes through transcriptional regulation of the hexokinase II gene. Am J Physiol Cell Physiol 2010; 298:C1560- C1571.
42. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
43. Nicoletti F, Fagone P, Meroni P, McCubrey J, Bendtzen K. mTOR as a multifunctional therapeutic target in HIV infection. Drug Dis Today 2011; 16:715-721.
44. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4:891-899.
45. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 2006; 66:5216-5223.
46. Montel-Hagen A, Kinet S, Manel N, Mongellaz C, Prohaska R, Battini JL, et al. Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell 2008; 132:1039-1048.
47. Munoz E, Blazquez MV, Ortiz C, Gomez-Diaz C, Navas P. Role of ascorbate in the activation of NF-kappaB by tumour necrosis factor-alpha in T-cells. Biochem J 1997; 325 (Pt 1):23-28.
48. Powell JD, Pollizzi KN, Heikamp EB, Horton MR. Regulation of immune responses by mTOR. Annu Rev Immunol 2012; 30:39- 68.